FDA commissioner calls on insurers to support drug development

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Commissioner: Insurers Need To Support Studies In Accelerated Drug Approval Pathway Physicians face a lot of barriers from insurers in completing studies on drugs in the accelerated approval pathway, declared Dr. Robert Califf, commissioner of food and drugs at the Food and Drug Administration. Insurers need to help, he said during the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum.  Save $600 with Spring Networking Madness We're ready for spring, are you? In our enthusiasm for spring, we're bringing you a special limited time discount of $600 to attend INVEST, the premier healthcare networking event of 2023. Offer Ends 3/26 - Register Now!

Featured News

Joint Commission CEO Wants to "Dispel the Myth" that Decarbonizing Healthcare Is Costly Some actions to reduce healthcare's carbon footprint actually will save money, said Jonathan Perlin, CEO of the nonprofit national and international accrediting organization. NAACP, Lawmakers File Federal Complaints Over Wellstar's Hospital Closures in Black Communities Georgia policymakers, county officials and the NAACP are asking the federal government to investigate Wellstar Health System's closure of two Atlanta-area hospitals in predominantly Black neighborhoods. Complaints have recently been filed with the DOJ, IRS and HHS' civil rights office. Pfizer's Migraine Drug Approval Triggers $475M Payment to Royalty Pharma Royalty Pharma's milestone payment from the approval of Pfizer migraine drug Zavzpret stems from financing deals struck with the therapy's previous developer, Biohaven Pharmaceuticals. Royalty Pharma is also in line to receive royalty payments going beyond the next decade. Register Now for INVEST and Be Part of the Conversation on Violence Against Healthcare Workers Violence against healthcare workers is a rising concern as hospitals struggle to retain and add staff. Don't miss the compelling discussion on the root causes of this violence and what's being done about it. Solution to Clinical Trial Enrollment Lies Hidden in FDA Guidance The FDA is apparently open to new technologies that enable patients to easily participate in clinical research, whether it be from their homes, a nearby clinic, or a provider's office. Pill Vaccine Biotech Vaxart Suspends Covid-19 Trial, Keeps Norovirus Focus Vaxart says its pill vaccines for Covid-19 still have advantages over injectable ones, but norovirus offers a faster path to validating its technology. The company is shelving its Covid-19 clinical trial in a corporate restructuring that will shave headcount by 27%. Patient Engagement in Virtual Mental Healthcare Requires Deep Understanding, Flexibility and Creativity The best approach to addressing this shortage of behavioral health professionals is more widespread adoption of virtual mental healthcare, a method of care delivery that is particularly appealing to college students.

Resources

Introducing MedCity Moves, a New Podcast on Healthcare's Corporate Ladder In the first episode, aside from providing an overview of healthcare's latest leadership and layoff news, Senior Reporter Katie Adams interviews Dr. Taha Kass-Hout, who recently became GE Healthcare's chief technology officer, about healthcare's corporate ladder. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe